Clinical Trials Logo

Sporotrichosis clinical trials

View clinical trials related to Sporotrichosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00004938 Completed - Sporotrichosis Clinical Trials

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

Start date: August 1996
Phase: Phase 2
Study type: Interventional

OBJECTIVE: I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.

NCT ID: NCT00004811 Completed - Histoplasmosis Clinical Trials

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis

Start date: March 1985
Phase: Phase 1/Phase 2
Study type: Interventional

OBJECTIVES: I. Evaluate the tolerance of patients with blastomycosis, histoplasmosis, and sporotrichosis to different doses of itraconazole (R51,211). II. Determine levels of itraconazole in serum and other body fluids. III. Assess the course of illness during itraconazole therapy. IV. Determine the dosage of itraconazole that is safe and well tolerated by 80%-90% of patients and estimate the potential of this dosage for use in future comparative trials.

NCT ID: NCT00004808 Completed - Histoplasmosis Clinical Trials

Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

Start date: September 1991
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Identify a preferred oral fluconazole dose regimen for patients with non-acute histoplasmosis or blastomycosis, or ulcerocutaneous or deep sporotrichosis. II. Study the safety and efficacy of fluconazole in these patients.